MAR 31, 2016 1:45 PM PDT

Scientists Find Cure For Mysterious Flemish Disease

WRITTEN BY: Kara Marker
A painful inflammatory disease has been plaguing a Flemish family for more than three generations, and for the first time in ten years scientists have identified both the mutation responsible and a potential treatment for the disease.

The genetic disease, which affects about half of each infected person’s children, causes painful skin lesions, fevers, pain, and exhaustion. Through modern DNA sequencing technology, scientists from the University of Leuven, Belgium and the Walter and Elisa Hall Institute, Australia were finally able to shine a light on the mutation responsible for the family’s painful legacy.

The dominant mutation occurs on a gene called MEFV, a gene also responsible for an inflammatory disease called Familial Mediterranean Fever (FMF). However, patients with FMF must inherit mutations from both their mother and their father, and the disease can skip generations, leading the scientists to believe that this disease is recessive. Only a single copy of the MEFV mutation linked to the Flemish family is needed to cause the recently understood disease.

The disease occurring from the dominant mutation on MEFV is now being referred to as Pyrin Associated Autoinflammation with Neutrophilic Dermatosis (PAAND), and after their genetic sequencing information came back, scientists found the same mutation in English and French families in addition to the Flemish family.

"The PAAND mutation causes the body to respond as if there is a bacterial skin infection,” said Seth Masters, PhD, from the Walter and Elisa Hall Institute. “This leads to the skin making the inflammatory protein interleukin-1β, which causes skin lesions, fevers and pain."
 
Pyoderma injury, characteristic of PAAND

In healthy people, interleukin-β is produced when macrophages are activated during a pathogenic infection. Interleukins are cytokines that, in addition to stimulating the immune response that is responsible for the symptoms of PAAND, aids in cell proliferation, differentiation, and apoptosis (RefSeq). Although interleukin-β is essential to daily immune defense, producing the cytokine at the wrong time and for the wrong reasons can clearly wreak havoc on the body.

Along with the discovery of the disease-causing mutation came the development of a cure. Scientists were actually able to build off of an already existing drug called anakinra, used as an anti-arthritis medication.

Anakinra is the main ingredient of a drug called Kineret which is used to treat another autoimmune disease, rheumatoid arthritis . Kineret comes from a class of therapies that target interleukin receptors to block activity; in the case of rheumatoid arthritis, the activity being blocked prevents joint damage and pain (Kineretrx.com).

After administering the drug for the first time, the scientists quickly saw skin lesions clear and a full recovery from fevers and pain. A large clinical trial will soon begin for PAAND patients from the Flemish family to understand how the new treatment could have potential as a complete cure.
The study from University of Leuven, Belgium and the Walter and Elisa Hall Institute, Australia was published in the journal Science Translational Medicine. 
 

Source: The Flanders Institute for Biotechnology
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 05, 2021
Immunology
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
OCT 05, 2021
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
Months after COVID symptoms have subsided, some individuals continue to grapple with the lingering effects of the infect ...
OCT 08, 2021
Microbiology
'Living Medicines' to Destroy Dangerous Biofilms
OCT 08, 2021
'Living Medicines' to Destroy Dangerous Biofilms
Bacteria that grow in colonies can be extremely difficult to eliminate; the bacteria in these groups often become resist ...
OCT 15, 2021
Health & Medicine
The Art of the Smize: Study Shows Eyes are More Active in Smiling Behind a Mask
OCT 15, 2021
The Art of the Smize: Study Shows Eyes are More Active in Smiling Behind a Mask
Mask wearing has become a part of our everyday lives. Something that we have all adapted to because of this is expressin ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
OCT 19, 2021
Cardiology
Can Optimism Save Lives?
OCT 19, 2021
Can Optimism Save Lives?
Throughout history, optimism has been viewed as a cornerstone of resilience. In the words of Helen Keller, optimism is t ...
OCT 21, 2021
Microbiology
Ongoing Salmonella Outbreak Traced to Onions
OCT 21, 2021
Ongoing Salmonella Outbreak Traced to Onions
On October 20, 2021, the Centers for Disease Control and Prevention (CDC) announced that an outbreak of Salmonella food ...
Loading Comments...